{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-005050","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.968621+00:00","generated_at":"2026-05-28T03:44:00.200040+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GoodRx CFO Karsten Voermann resigns; CAO Romin Nabiey named interim CFO","bullets":["Karsten Voermann resigns as CFO effective Jan 17, 2025, for personal reasons, not due to any disagreement.","Romin Nabiey, current Chief Accounting Officer, appointed Interim CFO and principal financial officer.","Nabiey will continue as CAO; has been with GoodRx since 2017 in various finance roles.","Voermann's vested stock options remain exercisable through Jan 17, 2026; he retains earned 2024 bonus.","Company begins search for permanent CFO."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-005050","json":"https://secwatch.observer/filing/0001193125-25-005050.json","markdown":"https://secwatch.observer/filing/0001193125-25-005050.md","text":"https://secwatch.observer/filing/0001193125-25-005050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/0001193125-25-005050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/d926337d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:44:00.200040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3849605203","claim":"Romin Nabiey was appointed as Interim Chief Financial Officer at GoodRx Holdings, Inc..","evidence_excerpt":"On January 10, 2025, the Board of Directors (the “Board”) of the Company appointed Romin Nabiey, the Company’s current Chief Accounting Officer, as Interim Chief Financial Officer of the Company, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/0001193125-25-005050-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a2a6695b4a","claim":"Karsten Voermann resigned as Chief Financial Officer at GoodRx Holdings, Inc..","evidence_excerpt":"On January 7, 2025, Karsten Voermann submitted his resignation as Chief Financial Officer of GoodRx Holdings, Inc. (the “Company”), effective January 17, 2025 (the “Effective Date”) for personal reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/0001193125-25-005050-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}